Early and Deep Molecular Responses Achieved with Frontline Asciminib in Chronic Phase CML - Interim Results from ALLG CML13 Ascend-CMLDavid T Yeung, Timothy P. Hughes, John Reynolds et al.|Blood|2022Cited by 4